The applying of immunohistochemical method for evaluating the cytoprotective effect of antidiabetic drugs

Resume. The article describes the experience of using the immunohistochemical method of analysis with anti-insulin monoclonal antibodies to assess the cytoprotective effect of lithium salts (carbonate and chloride) on pancreatic p-cells. The main advantage of this method over the classical staining methods, which reveal all types of Langerhans' cells, is selective insulin-producing p-cells identification. On the model of streptozotocin-induced type 2 diabetes in Wistar rats, a significant reduction in the p-cells number and a violation of their morphological structure was shown. Both lithium salts are known to be the GSK-3P inhibitors. Our experiments revealed the pronounced cytoprotective activity, consisting in restoring of the insulinocytes' morphological characteristics, increasing the p-cells absolute and relative quantity and the percentage of small and medium-sized islets. A satisfactory correlation between the degree of the lithium salts cytoprotective effect and their hypoglycemic activity has been revealed.

диабета 2 типа, стрептозотоцин, лития хлорид, лития карбонат, р-клетки, цитопротекция, diabetes 2 type, streptozotocin, GSK-3P, lithium salts, p-cells, cytoprotection, immunohistochemistry

1. Дедов И.И., Шестакова М.В. Клинические рекомендации. Алгоритмы специализированной медицинской помощи больным сахарным диабетом // Сахарный диабет. – 2015. – №18(1S). – С.1–112. [Dedov II, Shestakova MV. Standards of specialized diabetes care. Diabetes Mellitus. 2015;18(1S):1–112. (In Russ).] DOI: 10.14341/DM20151S1-112

2. Петеркова В.А., Лаптев Д.Н. Перспективы терапии, направленной на восстановление пула β-клеток, при сахарном диабете // Сахарный диабет. – 2009. – №3 – C.6–9. [Peterkova VA, Laptev DN. Prospects for therapy aimed at restoring the beta-cells pool in patients with diabetes mellitus (review of literature). Diabetes Mellitus. 2009;3:6–9. (In Russ).]

3. Woodgett JR. Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders. Curr Drug Targets Immune Endocr Metabol Disord. 2003;3(4):281–290.

4. Ostrovskaya RU, Zolotov NN, Ozerova IV, et al. Noopept normalizes parameters of the incretin system in rats with experimental diabetes. Bull Exp Biol Med. 2014;157(3):344–349. DOI: 10.1007/s10517-014-2562-5

5. Ostrovskaya RU, Yagubova SS, Gudasheva TA, et al. Low-MolecularWeight NGF Mimetic Corrects the Cognitive Deficit and Depression-like Behavior in Experimental Diabetes. Acta Naturae. 2017;9(2):94–102.

6. Снигур Г.Л., Смирнов А.В. К вопросу стандартизации патогистологической диагностики сахарного диабета // Вестник ВолГМУ. – 2010. – №3 (35) – С.112–118. [Snigur GL, Smirnov AV. To the question of standardization of pathohistological diagnostics of the diabetes mellitus. Vestnik VolGMU. 2010;3(35);112–118. (In Russ).]

7. Feng ZC, Donnelly L, Li J, et al. Inhibition of Gsk3β activity improves β-cell function in c-KitWv/+ male mice. Lab. Invest. 2012;92(4):543–555. DOI: 10.1038/labinvest.2011.200

8. Novelli M, Bonamassa B, Masini M, et al. Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger. Naunyn Schmiedebergs Arch Pharmacol. 2010;382(2):127–137. DOI: 10.1007/s00210-010-0524-7